Insmed
INSM
#959
Rank
HK$196.77 B
Marketcap
HK$896.98
Share price
5.19%
Change (1 day)
-39.90%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2023 (TTM): -HK$41.28

According to Insmed's latest financial reports the company's current EPS (TTM) is -HK$22.11. In 2022 the company made an earnings per share (EPS) of -HK$30.58 a decrease over its 2021 EPS that were of -HK$30.34.

EPS history for Insmed from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$41.2835%
2022-HK$30.580.78%
2021-HK$30.3428.57%
2020-HK$23.60-0.99%
2019-HK$23.83-27.96%
2018-HK$33.0947.55%
2017-HK$22.420.7%
2016-HK$22.2739.9%
2015-HK$15.929.73%
2014-HK$14.5017.09%
2013-HK$12.390.64%
2012-HK$12.31-46.42%
2011-HK$22.97497.96%
2010-HK$3.84-105.1%
2009HK$75.35-850.78%
2008-HK$10.04-24.71%
2007-HK$13.33-71.67%
2006-HK$47.04-28.57%
2005-HK$65.8623.53%
2004-HK$53.31134.48%
2003-HK$22.74-73.64%
2002-HK$86.24-2.65%
2001-HK$88.60-86.64%
2000-HK$663.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.16-286.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-HK$24.31 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$135.87-714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-HK$20.62-6.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.88-73.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-HK$7.68-65.25%๐Ÿ‡บ๐Ÿ‡ธ USA